Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection

Luke Blagdon Snell, Adela Alcolea-Medina, Themis Charalampous, Christopher Alder, Tom G.S. Williams, Flavia Flaviani, Rahul Batra, Prijay Bakrania, Rajeni Thangarajah, Stuart Neil, Claire van Nispen tot Pannerden, Alina Botgros, Emma J. Aarons, Sam T Douthwaite, Jonathan Edgeworth, Gaia Nebbia

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
79 Downloads (Pure)

Abstract

The management of COVID-19 has become more complex due to the expansion of available therapies. The presence of SARS-CoV-2 variants and mutations further complicate treatment due to their differing susceptibilities to therapies. Here we outline the use of real-time whole genome sequencing to characterise infections and guide treatment decisions.
Original languageEnglish
JournalClinical Infectious Diseases
DOIs
Publication statusAccepted/In press - 26 Oct 2022

Keywords

  • COVID-19
  • SARS-CoV-2
  • whole genome sequencing

Fingerprint

Dive into the research topics of 'Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection'. Together they form a unique fingerprint.

Cite this